Dear Wellcome Sanger Institute / COVID-19 Cell Atlas Team,
I am writing to enquire whether it would be possible to submit my dataset to the COVID-19
Cell Atlas. My data focus on Post-COVID-19 interstitial lung disease (ILD), including both
5' single cell RNA-seq peripheral blood mononuclear cells (PBMC) and bronchoalveolar
lavage (BAL) samples.
I believe these data could complement your existing datasets, which primarily focus on
acute COVID-19, by providing additional insight into the longer-term systemic
immunological and pulmonary consequences of infection.
I would be very happy to provide further details about the dataset, including experimental
design, metadata, and processing pipelines, if this would be of interest. These data were
generated as part of a UK-ILD consortium, including UCL, Imperial and international
collaboration with Yale University.
We are planning to publish the manuscript on bioarchives on May 11th, ahead of an oral
presentation of these data at the American Thoracic Society (ATS) Annual Conference in
Orlando, USA.
Please could you let us know if our data submission is of interest to you and could you
provide details of the process and any associated costs?
Thank you for your time and consideration, and I look forward to your response.
Kind regards,
Dr. Puja Mehta